Eradication of rat malignant gliomas by retroviral-mediated, in vivo delivery of the interleukin 4 gene

Cancer Research

Volumn 59, Issue 3, 1999, Pages 645-652

  Benedetti, Sara ^a   Bruzzone, Maria Grazia ^a,c   Pollo, Bianca ^a,c   DiMeco, Francesco ^a   Magrassi, Lorenzo ^a   Pirola, Barbara ^a   Cirenei, Nicola ^a   Colombo, Mario P ^b   Finocchiaro, Gaetano ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER THERAPY; CYTOKINE PRODUCTION; FEMALE; GENE TARGETING; GENE THERAPY; GLIOBLASTOMA; IMMUNOSTIMULATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RETROVIRUS;

ANIMALS; BRAIN NEOPLASMS; CD8-POSITIVE T-LYMPHOCYTES; DNA, COMPLEMENTARY; FEMALE; GENE THERAPY; GLIOMA; INTERLEUKIN-4; MICE; RATS; RATS, INBRED F344; RATS, SPRAGUE-DAWLEY; RETROVIRIDAE;

EID: 0033083907     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Roszman, T., Elliott, W., and Brooks, W. Modulation of T-cell function by gliomas. Immunol. Today, 12: 507-512, 1991.
2. Mahaley, M. S., Jr., Brooks, W. H., Roszman, T. L., Bigner, D. D., Dudka, L., and Richardson. S. Immunobiology of primary intracranial tumors. Part 1: studies of the cellular and humoral general immune competence of brain tumor patients. J. Neurosurg., 46: 467-476, 1977.
3. Tada, M., and De Tribolet, N. Recent advances in immunobiology of brain tumors. J. Neuro-Oncol., 17: 261-271, 1993.
4. Cserr, H. F., and Knopf, P. M. Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. Immunol. Today, 13: 507-512, 1992
5. Weller, R. O., Engelhardt, B., and Phillips, M. J. Lymphocyte targeting of the central nervous system: a review of afferent and efferent CNS-immune pathways. Brain Pathol., 6: 275-288, 1996.
6. Gordon, L. B., Nolan, S. C. Cserr, H. F., Knopf, P. M., and Harling-Berg, C. J. Growth of P511 mastocytoma cells in BALB/c mouse brain elicits CTL response without tumor elimination: a new tumor model for regional central nervous system immunity. J. Immunol., 159: 2399-2408, 1997.
7. Weller, M.,and Fontana, A. The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-β, T-cell apoptosis, and the immune privilege of the brain. Brain Res. Rev., 21: 128-151, 1995.
8. Hishii, M., Nitta, T., Ishida, H., Michimasa, E., Kurosu, A., Yagita, H., Sato, K., and Okumura, K. Human glioma-derived interleukin-10 inhibits antitumor immune responses in vitro. Neurosurgery, 37: 1160-1167, 1995.
9. Saas, P., Walker, P. R., Hahne, M., Quiquerez, A. L., Schnuriger, V., Perrin, G., French, L., Van Meir, E. G., deTribolet, N., Tschopp, J., and Dietrich, P. Y. Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? J. Clin. Invest., 99: 1173-1178, 1997.
10. Tepper, R. I., Pattengale, P. K., and Leder, P Murine interleukin-4 displays potent anti-tumor activity in viro. Cell, 57: 503-512, 1989.
11. Pericle, F., Giovarelli, M., Colombo, M. P., Ferrari, G., Musiani, P., Modesti, A., Cavallo, F., DiPierro, F., Novelli, F., and Forni, G. An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of spontaneous mouse mammary adenocarcinoma engineered to release IL-4. J. Immunol., 153: 5659-5673, 1994.
12. Yu, J. S., Wei, M. X., Chiocca, E. A., Martuza, R. L., and Tepper, R. I. Treatment of glioma by engineered interleukin 4-secreting cells. Cancer Res., 53: 3125-3128, 1993.
13. Wei, M. X., Tamiya, T., Hurford, R. K., Jr., Boviatsis, E. J., Tepper, R. I., and Chiocca, E. A. Enhancement of interleukin-4-mediated tumor regression in athymic mice by in situ retroviral gene transfer. Hum. Gene Ther. 6: 437-443, 1995.
14. Wei, M. X., Li. F., Ono, Y., Gauldie, J., and Chiocca, E. A. Effects on brain tumor cell proliferation by an adenovirus vector that bears the interleukin-4 gene. J. Neurovirol., 4: 237-241, 1998.
15. Tseng, S. H., Hwang, L. H., and Lin, S. M. Induction of antitumor immunity by intracerebrally implanted rat C6 glioma cells genetically engineered to secrete cytokines. J. Immunother., 20: 334-342, 1997.
16. Sampson, J. H., Ashley, D. M., Archer, G. E., Fuchs, H. E., Dranoff, G., Hale, L. P., and Bigner, D. D. Characterization of a spontaneous murine astrocytoma and abrogation of its tumorigenicity by cytokine secretion. Neurosurgery, 41: 1365-1372. 1997.
17. Benedetti, S., DiMeco, F., Pollo, B., Cirenei, N., Colombo, B. M., Bruzzone, M. G., Cattaneo, E., Vescovi, A., DiDonato, S., Colombo, M. P., and Finocchiaro, G. Limited efficacy of the HSV-TK/GCV system for gene therapy of malignant gliomas and perspectives for the combined transduction of the interleukin-4 gene. (1997) Hum. Gene Ther., 8: 1345-1353, 1997.
18. Andreasky, S., van Cott, J., McGhee, J., Markertr, J. M., Gillespie, G. Y., Roizman, B., and Whitley, R. J. Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins. Gene Ther., 5: 121-130, 1998.
19. Colombo, B. M., Benedetti, S., Ottolenghi, S., Poli, G., Pollo, B., Mora, M., and Finocchiaro G. The. "bystander effect": association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. Hum. Gene Ther., 6: 763-772, 1995.
20. Beutler, A. S., Banck, M. S., Aguzzi, A., Wedekind, D., and Hedrich, H. J. Curing rat glioblastoma: immunotherapy or graft rejection? Science (Washington DC), 276: 20-21, 1997.
21. Izquierdo, M., Cortes, M. de Felipe, P., Martin, V., Diez-Guerra, J., Talavera, A., and Perez-Higueras, A. Long-term rat survival after malignant brain tumor regression by retroviral gene therapy. Gene Ther., 2: 66-69, 1995.
22. Chicoine, M. R., and Silbergeld, D. L. Invading C6 glioma cells maintaining tumorigenicity. J. Neurosurg., 83: 665-671, 1995.
23. Barth, R. F. Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J. Neurooncol., 36: 91-102, 1998.
24. Ram, Z., Culver, K. W., Walbridge, S., Blaese, R. M., and Oldfield, E. H. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res., 53: 83-88, 1993
25. Tepper, R. I., Pattengale, P. K., and Leder, P. Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell, 57: 503-512, 1989.
26. Noffz, G., Qin, Z., Kopf. M., and Blankestein, T. Neutrophils but not eosinophils are involved in growth suppression of IL-4 secreting tumors. J. Immunol., 160: 345-350, 1998.
27. Puri, R. K., Leland, P., Kreitman, R. J., Pastan, I. Human neurological cancer cells express interleukin-4 (IL-4) receptors which are targets for the toxic effects of ILA-Pseudomonas exotoxin chimeric protein. Int. J. Cancer, 58: 574-581, 1994.
28. Barna, B. P., Estes, M. L., Pettay, J., Iwasaki, K., Zhou, P., and Barnett, G. H. Human astrocyte growth regulation: interleukin-4 sensitivity and receptor expression. J. Neuroimmunol., 60: 75-81, 1995.
29. Topp, M. S., Papadimitriou, C. A., Eitelbach, F., Koenigsmann, M., Oelmann, E., Koehler, B., Oberberg, D., Reufi, B., Stein, H., Thiel, E, and Berdel, W. E. Recombinant human interleukin 4 has antiproliferative activity on human tumor cell lines derived from epithelial and nonepithelial histologies. Cancer Res., 55: 2173-2176, 1995.
30. Davis, F. G., Freels, S., Grutsch, J., Barlas, S., Brem, S. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance. Epidemiology, and End Results (SEER) data, 1973-1991. J. Neurosurg., 88: 1-10, 1998.
31. Culver, K. W., Ram, Z., Walbridge, S., Ishii, H., Oldfield, E. H., and Blaese, R. M. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science (Washington DC), 256: 1550-1552, 1992.
32. Ram, Z., Culver, K. W., Oshiro, E. M., Viola, J. J., DeVroom, H. L., Otto, E., Long, Z., Chiang, Y., McGarrity, G. J., Muul, L. M., Katz, D., Blaese, R. M . and Oldfield, E. H. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat. Med., 3: 1354-1361, 1997.
33. Kock, H., Harris, M. P., Anderson, S. C., Machemer, T., Hancock, W., Sutjipto, S., Wills, K. N., Gregory, R. J., Shepard, H. M., Westphal, M., and Maneval, D. C. Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo. Int. J. Cancer, 67: 808-815, 1996.
34. Schnierle, B. S., and Groner, B. Retroviral targeted delivery. Gene Ther., 3: 1069-1073, 1996.
35. Miyatake, S., Martuza, R. L., and Rabkin, S. D. Defective herpes simplex virus vectors expressing thymidine kinase for the treatment of malignant glioma. Cancer Gene Ther., 4: 222-228, 1997.
36. Ohara, J., and Paul, W. E. Receptors for B-cell stimulatory factor-1expressed on cells of haematopoietic lineage. Nature (Lond.), 325: 537-540, 1981.
37. Mosmann, T. R., Yokota, T., Kastelein, R., Zurawski, S. M., Arai, N., and Takebe, Y. Species-specificity of T cell stimulating activities of IL-2 and BSF-1 (IL-4): comparison of normal and recombinant, mouse and human IL-2 and BSF-1 (IL-4). J. Immunol., 138: 1813-1816, 1987.
38. Levy, A. E., and Alexander, J. W. Administration of intragraft interleukin-4 prolongs cardiac allograft survival in rats treated with donor-specific transfusion/cyclosporine. Transplantation, 60: 405-406, 1995.
39. Cattaneo, E., Magrassi, L., Butti, G., Santi, L., Giavazzi, A., and Pezzotta, S. A short term analysis of the behaviour of conditionally immortalized neuronal progenitors and primary neuroepithelial cells implanted into the fetal rat brain. Brain Res. Dev. Brain Res., 83: 197-208, 1994.
40. Ram, Z., Walbridge, S., Heiss, J. D., Culver, K. W., Blaese, R. M., and Oldileld, E. H. In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors. J. Neurosurg., 80: 535-540, 1994.
41. Tjuvajev, J., Gansbacher, B., Desai, R., Beattie, B., Kaplitt, M., Matei, C., Koutcher, J., Gilboa, E., and Blasberg R RG-2 glioma growth attenuation and severe brain edema caused by local production of inlerleukin-2 and inlerferon-γ. Cancer Res., 55: 1902-1910, 1995.
42. Lefranc, F., Pirotte, B., Bakkus, M., Dargent, J. L., Baudson, N., Brotchi, J., Thielemans, K., Velu, T., and Cool, V. GM-CSF gene transfer in 9L tumor cells induces a loss of tumorigenicity, a protective immune response against s.c. and i.e. challenge, and a therapeutic antitumoral immune response. Gene Ther., 2 (Suppl. 1): S25, 1995.
43. Volpert. O. V., Fong T., Koch, A. E., Peterson, J. D., Waltenbaugh, C., Tepper, R. I., and Bouck, N. P. Inhibition of angiogenesis by interleukin 4. J. Exp. Med., 188: 1039-1046, 1998.
44. Saleh, M. I., Davis, D., and Wilks, A. F. The paracrine role of tumor-derived mlL-4 on tumor-associated endothelium. Int. J. Cancer, 72: 664-672, 1997.